Pennsylvania Trust Co increased its position in shares of Cognex Co. (NASDAQ:CGNX) by 5.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,999 shares of the scientific and technical instruments company’s stock after purchasing an additional 2,440 shares during the quarter. Pennsylvania Trust Co’s holdings in Cognex were worth $2,846,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CGNX. PNC Financial Services Group Inc. lifted its stake in Cognex by 9.6% during the first quarter. PNC Financial Services Group Inc. now owns 29,650 shares of the scientific and technical instruments company’s stock worth $1,542,000 after purchasing an additional 2,597 shares during the last quarter. Russell Investments Group Ltd. lifted its stake in Cognex by 12.5% during the first quarter. Russell Investments Group Ltd. now owns 113,923 shares of the scientific and technical instruments company’s stock worth $5,903,000 after purchasing an additional 12,643 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec bought a new position in Cognex during the first quarter worth $213,000. Asset Management One Co. Ltd. lifted its stake in Cognex by 2.4% during the first quarter. Asset Management One Co. Ltd. now owns 259,332 shares of the scientific and technical instruments company’s stock worth $13,483,000 after purchasing an additional 5,996 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its stake in Cognex by 2.8% during the first quarter. Principal Financial Group Inc. now owns 759,460 shares of the scientific and technical instruments company’s stock worth $39,484,000 after purchasing an additional 20,959 shares during the last quarter. Hedge funds and other institutional investors own 90.28% of the company’s stock.

Several equities analysts recently issued reports on the company. Zacks Investment Research upgraded Cognex from a “sell” rating to a “hold” rating in a research note on Tuesday, July 3rd. BidaskClub upgraded Cognex from a “hold” rating to a “buy” rating in a research note on Wednesday, September 26th. Northcoast Research set a $56.00 price objective on Cognex and gave the stock a “buy” rating in a research note on Tuesday, July 31st. ValuEngine raised Cognex from a “strong sell” rating to a “sell” rating in a research report on Tuesday, July 31st. Finally, Morgan Stanley began coverage on Cognex in a research report on Monday, August 20th. They issued an “equal weight” rating and a $57.00 target price on the stock. Four analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $55.01.

Shares of NASDAQ CGNX opened at $45.61 on Thursday. Cognex Co. has a 1-year low of $39.90 and a 1-year high of $72.99. The firm has a market capitalization of $9.60 billion, a price-to-earnings ratio of 31.46 and a beta of 1.64.

Cognex (NASDAQ:CGNX) last issued its earnings results on Monday, July 30th. The scientific and technical instruments company reported $0.32 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.02. Cognex had a return on equity of 22.95% and a net margin of 20.57%. The firm had revenue of $211.26 million for the quarter, compared to analyst estimates of $204.87 million. During the same period last year, the company earned $0.63 earnings per share. The firm’s revenue for the quarter was up 18.6% on a year-over-year basis. Equities analysts anticipate that Cognex Co. will post 1.19 EPS for the current fiscal year.

In other Cognex news, Director Jerry A. Schneider sold 5,000 shares of the stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $54.29, for a total value of $271,450.00. Following the sale, the director now directly owns 7,000 shares of the company’s stock, valued at $380,030. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Anthony Sun sold 10,000 shares of the firm’s stock in a transaction on Monday, August 6th. The shares were sold at an average price of $53.01, for a total value of $530,100.00. Following the transaction, the director now directly owns 284,262 shares in the company, valued at $15,068,728.62. The disclosure for this sale can be found here. Insiders sold 27,500 shares of company stock worth $1,493,200 over the last ninety days. 5.40% of the stock is owned by corporate insiders.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. The company offers machine vision products, which are used to automate the manufacturing and tracking of discrete items, such as mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Featured Article: Terms to Better Understand Call Options

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.